Skip to main content
placeholder image

A phase I trial of AEG35156 (XIAP antisense) administered as 2-hour intravenous infusions in patients with advanced tumours

Journal Article


Abstract


Publication Date


  • 2008

Citation


  • Jolivet, J., Dean, E., Ward, T. H., Denneny, O., Jacob, C., Goodege, P., . . . Ranson, M. (2008). A phase I trial of AEG35156 (XIAP antisense) administered as 2-hour intravenous infusions in patients with advanced tumours. Journal of Clinical Oncology, 26(15_suppl), 3541. doi:10.1200/jco.2008.26.15_suppl.3541

Web Of Science Accession Number


Start Page


  • 3541

End Page


  • 3541

Volume


  • 26

Issue


  • 15_suppl

Abstract


Publication Date


  • 2008

Citation


  • Jolivet, J., Dean, E., Ward, T. H., Denneny, O., Jacob, C., Goodege, P., . . . Ranson, M. (2008). A phase I trial of AEG35156 (XIAP antisense) administered as 2-hour intravenous infusions in patients with advanced tumours. Journal of Clinical Oncology, 26(15_suppl), 3541. doi:10.1200/jco.2008.26.15_suppl.3541

Web Of Science Accession Number


Start Page


  • 3541

End Page


  • 3541

Volume


  • 26

Issue


  • 15_suppl